Cargando…
Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis
One of the major challenges for discovering protein-protein interaction inhibitors is identifying selective and druggable binding sites at the protein surface. Here, we report an approach to identify a small molecular binding site to selectively inhibit the interaction of soluble RANKL and RANK for...
Autores principales: | Huang, Dane, Zhao, Chao, Li, Ruyue, Chen, Bingyi, Zhang, Yuting, Sun, Zhejun, Wei, Junkang, Zhou, Huihao, Gu, Qiong, Xu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468151/ https://www.ncbi.nlm.nih.gov/pubmed/36097003 http://dx.doi.org/10.1038/s41467-022-33006-4 |
Ejemplares similares
-
Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007) -
RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016) -
Mesenchymal Stromal Cell‐Seeded Biomimetic Scaffolds as a Factory of Soluble RANKL in Rankl‐Deficient Osteopetrosis
por: Menale, Ciro, et al.
Publicado: (2018) -
RANK/RANKL expression in prostate cancer
por: Ohtaka, Mari, et al.
Publicado: (2016) -
The Roadmap of RANKL/RANK Pathway in Cancer
por: Casimiro, Sandra, et al.
Publicado: (2021)